BioLineRx Growth Metrics (2023-2025) | BLRX

Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) -24.83%9.60%-0.21%-39.14%-15.68%-33.02%-24.53%
Assets (QoQ) -14.15%-10.32%20.94%-19.28%25.19%-18.35%-26.23%11.83%-0.56%-8.00%
Capital Expenditures Growth (1y) 0.00%59.70%-48.15%
Capital Expenditures (QoQ) -109.38%98.51%21,700.00%-114.81%15.63%
Cash & Equivalents Growth (1y) -33.93%-4.76%14.35%145.26%50.85%-25.29%-10.43%
Cash & Equivalents (QoQ) 11.45%-23.53%-44.93%40.78%60.65%-8.18%18.11%-13.42%-20.44%10.08%
Cash from Investing Activities Growth (1y) 151.23%-177.88%148.35%154.70%-149.00%57.15%-63.90%
Cash from Investing Activities (QoQ) 67.12%-63.09%-597.80%181.82%-151.81%217.70%9.65%-173.29%54.70%199.16%
Cash from Operations Growth (1y) -76.01%-17.01%0.77%-272.51%81.64%98.44%78.56%
Cash from Operations (QoQ) -20.78%-2.26%150.41%-382.69%19.70%13.28%12.37%69.91%93.17%-1,089.83%
EBITDA Margin Growth (1y) 130,182.00-137809.00135,856.00-202973.00202,074.00-130503.00-11102.00
EBITDA Margin (QoQ) 269,903.00-286340.00346,840.00-200221.001,913.00-12676.008,011.00204,826.00-330664.00106,725.00
EBIT Growth (1y) 45.55%41.78%56.41%76.16%50.41%60.11%59.03%
EBIT Margin Growth (1y) 88,500.0063,454.00136,736.00-202973.00-86730.00-65052.00-40788.00
EBIT Margin (QoQ) 21,375.00-73476.00346,840.00-206240.00-3670.00-194.007,131.00-89998.0018,008.0024,070.00
EBIT (QoQ) -11.96%-24.63%-50.25%74.03%-19.72%6.69%17.84%45.98%3.68%4.17%
EBT Growth (1y) 50.90%57.01%67.34%100.28%49.37%45.04%49.42%
EBT Margin Growth (1y) 79,855.0057,320.00130,024.00-209160.00-71615.00-59839.00-36956.00
EBT Margin (QoQ) 21,375.00-73476.00346,840.00-214885.00-1159.00-772.007,657.00-77340.0010,616.0022,111.00
EBT (QoQ) -8.19%-34.30%-69.25%80.03%5.27%-2.01%101.44%-3,750.00%-2.84%6.12%
Enterprise Value Growth (1y) 75.92%-95.32%-115.62%-104.52%-103.68%-471.78%3.54%
Enterprise Value (QoQ) 92.83%6.59%-20.53%7.70%-94.86%-455.33%77.02%12.15%-418.35%7.81%
EPS (Basic) Growth (1y) 58.30%63.48%74.83%100.21%75.36%73.25%74.44%
EPS (Basic) (QoQ) -8.19%-34.30%-68.14%82.93%5.27%7.45%101.43%-2,061.00%-2.84%11.55%
FCF Margin Growth (1y) 65,592.0050,958.0098,403.0043,810.00-81072.0015,134.00-29444.00
FCF Margin (QoQ) 14,213.00-46365.0067,046.0030,699.00-421.001,080.0012,453.00-94184.0095,785.00-43498.00
Free Cash Flow Growth (1y) -76.32%-17.55%0.76%-282.66%81.59%98.43%78.56%
Free Cash Flow (QoQ) -20.43%-2.96%148.23%-394.81%19.71%13.07%11.23%70.29%93.17%-1,089.83%
Gross Margin Growth (1y) 789.00-705.00-304.00
Gross Margin (QoQ) 459.000.00-3520.003,849.00-1035.00401.00
Gross Profit Growth (1y) -95.91%-94.84%-91.68%
Gross Profit (QoQ) -16.74%-8.34%37.35%-96.10%4.98%47.84%
Interest Coverage Ratio Growth (1y) -45.67%-62.66%-77.55%104.96%9.68%201.36%119.00%
Interest Coverage Ratio (QoQ) -22.37%99.08%-234.93%126.06%-46.66%19.73%-70.20%476.23%46.57%-13.00%
Net Cash Flow Growth (1y) 218.34%204.13%62.34%139.25%-178.27%-158.36%175.00%
Net Cash Flow (QoQ) 190.23%-279.52%-58.96%145.96%131.89%-122.23%265.67%-191.66%-72.91%128.57%
Net Income Growth (1y) 50.90%57.01%67.34%100.28%49.37%45.04%49.42%
Net Income (QoQ) -8.19%-34.30%-69.25%80.03%5.27%-2.01%101.44%-3,750.00%-2.84%6.12%
Net Income towards Common Stockholders Growth (1y) 50.90%57.01%67.34%100.28%49.37%45.04%49.42%
Net Income towards Common Stockholders (QoQ) -8.19%-34.30%-69.25%80.03%5.27%-2.01%101.44%-3,750.00%-2.84%6.12%
Net Margin Growth (1y) 79,855.0057,320.00130,024.00-209160.00-71615.00-59839.00-36956.00
Net Margin (QoQ) 21,375.00-73476.00346,840.00-214885.00-1159.00-772.007,657.00-77340.0010,616.0022,111.00
Operating Income Growth (1y) 45.55%41.78%56.41%76.16%50.41%60.11%59.03%
Operating Income (QoQ) -11.96%-24.63%-50.25%74.03%-19.72%6.69%17.84%45.98%3.68%4.17%
Operating Margin Growth (1y) 88,500.0063,454.00136,736.00-202973.00-86730.00-65052.00-40788.00
Operating Margin (QoQ) 21,375.00-73476.00346,840.00-206240.00-3670.00-194.007,131.00-89998.0018,008.0024,070.00
Profit After Tax Growth (1y) 88.36%92.36%91.16%0.00%0.00%0.00%0.00%
Profit After Tax (QoQ) -52.48%13.60%91.16%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Property, Plant & Equipment (Net) Growth (1y) -38.29%-46.91%-55.61%-18.39%-27.25%-42.73%-32.53%
Property, Plant & Equipment (Net) (QoQ) -2.70%-13.43%-15.69%-13.11%-16.30%-27.62%55.02%-22.54%-34.11%-14.72%
Return on Assets Growth (1y) 57.0053.0049.0038.00
Return on Assets (QoQ) 6.009.0014.0028.002.005.004.00
Return on Capital Employed Growth (1y) 251.00107.0099.0062.00
Return on Capital Employed (QoQ) 145.0022.0048.0035.001.0014.0011.00
Return on Equity Growth (1y) 690.00-12492.00-401.001,189.00
Return on Equity (QoQ) 13,181.00-12487.00-2.00-2.00-1.00-396.001,588.00
Return on Sales Growth (1y) 2,152.00495.00273.00144.00
Return on Sales (QoQ) 1,654.00219.00128.00151.00-3.00-3.00-1.00
Revenue Growth (1y) 639.48%303.37%490.56%1,360.62%-96.28%-94.36%-91.36%
Revenue (QoQ) 44.23%-37.40%-211.35%835.52%-21.33%-8.34%137.69%-97.83%19.22%40.46%
Shareholder's Equity Growth (1y) -14.36%-8.35%-5.29%-99.57%-0.87%202.00%-0.75%
Shareholder's Equity (QoQ) -5.42%-4.44%203.69%-200.18%0.12%-1.49%100.43%-23,441.22%201.00%-200.25%
Total Debt Growth (1y) -10.93%154.44%141.02%37.49%28.06%-61.97%-63.75%
Total Debt (QoQ) 7.18%-0.32%-15.28%-1.59%206.16%-5.58%-51.67%-8.34%-9.09%-9.99%